文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

泰国麻疹免疫强化:第三剂疫苗预防暴发的依据

Strengthening measles immunity in Thailand: Rationale for a third vaccine dose to avert outbreaks.
PubMed 文献 · Vaccine · 2026-03-10

研究基于2024年泰国四省3675份年龄代表性血清样本,以ELISA检测麻疹IgG(保护阈值≥200 IU/L),并与2004、2014年全国血清学调查比较。2024年总血清阳性率61.3%,呈U型年龄分布;14-31岁人群免疫力仅27%-46%,提示两剂常规免疫不足,需评估10-40岁第三剂强化策略。

要点

  • 2024年泰国麻疹总血清阳性率61.3%,低于群体免疫阈值92%以上。
  • 14-31岁青少年和年轻成人血清保护率仅27%-46%,为免疫薄弱人群。
  • 1985-2008年出生队列疫苗诱导免疫血清保护率逐步下降。

核心结论

  • 泰国当前麻疹免疫力低于阻止传播所需的群体免疫阈值(估计≥92%),青少年和成人高易感性提示两剂常规免疫不足。
  • 结果支持进一步评估针对性强化策略,包括对10-40岁人群接种第三剂含麻疹疫苗。

研究设计与样本

  • 使用2024年泰国四省采集的3675份年龄代表性血清样本评估麻疹特异性免疫。
  • 通过ELISA检测IgG浓度,保护阈值≥200 IU/L,并与2004年和2014年全国血清学调查比较。

主要发现

  • 2024年总血清阳性率为61.3%,呈明显U型年龄分布。
  • 40岁以上成人血清保护率高于95%,与自然感染一致。
  • 14-31岁青少年和年轻成人免疫力较低,范围为27%至46%。
  • 1985年至2008年出生队列疫苗诱导免疫的血清保护率逐步下降。
  • 2024年全国病例数据反映该发现,深南部以外省份多数感染发生在15岁以上人群。

关键数值与推荐

  • 麻疹IgG保护阈值定义为≥200 IU/L(ELISA检测)。
  • 阻止麻疹传播所需的群体免疫阈值估计为92%或更高。
  • 建议进一步评估对10-40岁人群接种第三剂含麻疹疫苗的强化策略。

临床怎么用

  • 将第三剂含麻疹疫苗纳入青少年或成人强化规划,并加强监测和低覆盖率地区的针对性补种。
  • 关注14-31岁青少年和年轻成人的免疫空白,优先评估强化接种需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Achieving measles elimination in Thailand requires restoring population immunity to levels sufficient to interrupt transmission. Recent outbreaks indicate widening immunity gaps despite long-standing national immunization programs. We assessed measles-specific immunity using 3675 age-representative serum samples collected in 2024 from four provinces. IgG concentrations were measured by ELISA with a protective threshold of ≥200 IU/L and interpreted alongside national serosurveys conducted in 2004 and 2014 to evaluate temporal changes in immunity across vaccine-era birth cohorts. Overall seropositivity in 2024 was 61.3% and showed a pronounced U-shaped age pattern. Adults older than 40 years had high seroprotection above 95% consistent with natural infection. Adolescents and young adults aged 14 to 31 years had much lower immunity ranging from 27% to 46%. Birth-cohort analysis revealed progressive declines in seroprotection among individuals born between 1985 and 2008, indicating low seroprevalence of vaccine-induced immunity. National case data from 2024 reflected these findings, with most infections outside deep southern provinces occurring in individuals older than 15 years. Thailand's current immunity levels fall below the herd immunity threshold needed to halt measles transmission, estimated at 92% or higher. The high susceptibility in adolescents and adults suggests that two routine doses are inadequate under current epidemiologic conditions. These results suggest the findings warrant further evaluation of targeted booster strategies, including potential role of a third measles-containing vaccine dose for individuals aged 10 to 40 years. Integrating this dose into adolescent or adult booster programs, along with strengthened surveillance and targeted catch-up vaccination in low-coverage regions, offers a practical pathway to closing immunity gaps and accelerating progress toward measles elimination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Nilyanimit P, Suntronwong N, Puenpa J, et al. Strengthening measles immunity in Thailand: Rationale for a third vaccine dose to avert outbreaks. Vaccine. 2026. PMID: 41812631. doi:10.1016/j.vaccine.2026.128438

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。